Ajax-Loading

Amgen Inc - Long Term Debt

Amgen Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Long-Term-Debt" stands at 52.43 Billion United States Dollars as of 09/30/2025, the lowest value since 03/31/2023.

As of the end of Amgen Inc's third quarter, the item "Long Term Debt" stands at 52.43 Billion USD. This represents a decrease of -2.47 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -7.77 percent compared to the value the year prior.
The 1 year change in percent is -7.77.
The 3 year change in percent is 41.10.
The 5 year change in percent is 53.33.
The 10 year change in percent is 71.85.

The Serie's long term average value is 33.82 Billion United States Dollars. It's latest available value, on 09/30/2025, is 55.03 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2011, to it's latest available value, on 09/30/2025, is +384.42%.
The Serie's change in percent from it's maximum value, on 12/31/2023, to it's latest available value, on 09/30/2025, is -17.00%.

Long Term Debt for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Long Term Debt905,699,262,464.00
LogoJohnson & Johnson - Long Term Debt486,508,953,600.00
LogoAbbVie Inc - Long Term Debt399,570,305,024.00
LogoRoche Holding AG - Long Term Debt317,433,206,677.55
LogoAstraZeneca PLC - Long Term Debt280,205,508,085.11